Media Center
-
The U.S. Food and Drug Administration Approves Pirtobrutinib (Jaypirca) for Relapsed/Refractory Mantle Cell Lymphoma
On January 27, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved pirtobrutinib…
-
The U.S. Food and Drug Administration Approves Zanubrutinib (Brukinsa) for Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL)
On January 19, the U.S. Food and Drug Administration (FDA) announced it has approved bruton tyrosine…
-
The U.S. Food and Drug Administration Approves Mosunetuzumab-axgb (Lunsumio) for Follicular Lymphoma
On December 22, 2022, the U.S. Food and Drug Administration (FDA) announced it has approved…
-
In Remembrance: Errol M. Cook
December 23, 2022 – It is with great sadness that the Lymphoma Research Foundation (LRF)…
-
Transforming Loss into Hope for Adolescents and Young Adults with Lymphoma
No parent should ever have to go through the excruciating experience of losing a child.…
MEDIA INQUIRIES:
We welcome members of the press to contact our Communications team at media@lymphoma.org with any media-related questions or interview requests.
